Jeroen Depreeuw

Identification of nine new susceptibility loci for endometrial cancer

Somatic <i>POLE</i> exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response

Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy

Genetic overlap between endometriosis and endometrial cancer: evidence from cross‐disease genetic correlation and GWAS meta‐analyses

Ischemia-Induced DNA Hypermethylation during Kidney Transplant Predicts Chronic Allograft Injury

Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways

Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma

Five endometrial cancer risk loci identified through genome-wide association analysis

Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer

CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer

Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies

Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1

Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer

Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer

Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk